Cargando…
Antiobesity and Antihyperglycemic Effects of Ginsenoside Rb1 in Rats
OBJECTIVE: Obesity and type 2 diabetes are national and worldwide epidemics. Because currently available antiobesity and antidiabetic drugs have limited efficacy and/or safety concerns, identifying new medicinal agents, such as ginsenoside Rb1 (Rb1) as reported here, offers exciting possibilities fo...
Autores principales: | Xiong, Ye, Shen, Ling, Liu, Kristina J., Tso, Patrick, Xiong, Yuqing, Wang, Guangji, Woods, Stephen C., Liu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279544/ https://www.ncbi.nlm.nih.gov/pubmed/20682695 http://dx.doi.org/10.2337/db10-0315 |
Ejemplares similares
-
Brain Apolipoprotein E: an Important Regulator of Food Intake in Rats
por: Shen, Ling, et al.
Publicado: (2008) -
Antiobesity Effect of Eicosapentaenoic Acid in High-Fat/High-Sucrose Diet–Induced Obesity: Importance of Hepatic Lipogenesis
por: Sato, Ayumi, et al.
Publicado: (2010) -
Ginsenoside Rb1 increases insulin sensitivity by activating AMP-activated protein kinase in male rats
por: Shen, Ling, et al.
Publicado: (2015) -
Antihyperglycemic and Antiobesity Effects of JAL2 on db/db Mice
por: Lee, In-Seung, et al.
Publicado: (2016) -
Antiobesity, Antihyperglycemic, and Antidepressive Potentiality of Rice Fermented Food Through Modulation of Intestinal Microbiota
por: Hor, Papan Kumar, et al.
Publicado: (2022)